Total Payments
$1,282
2023 Payments
$12.80
Companies
18
Transactions
81
Payment Breakdown by Category
Food & Beverage$1,170 (91.3%)
Education$111.80 (8.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,170 | 79 | 91.3% |
| Education | $111.80 | 2 | 8.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $339.39 | 20 | $0 (2019) |
| Genentech USA, Inc. | $235.96 | 17 | $0 (2018) |
| PFIZER INC. | $189.93 | 16 | $0 (2023) |
| Shire North American Group Inc | $99.00 | 1 | $0 (2017) |
| E.R. Squibb & Sons, L.L.C. | $73.33 | 6 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $58.89 | 4 | $0 (2017) |
| Dendreon Pharmaceuticals LLC | $43.32 | 2 | $0 (2017) |
| Teva Pharmaceuticals USA, Inc. | $38.29 | 2 | $0 (2017) |
| Foundation Medicine, Inc. | $31.24 | 2 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $28.82 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $12.80 | 1 | PFIZER INC. ($12.80) |
| 2020 | $12.49 | 1 | PFIZER INC. ($12.49) |
| 2019 | $139.89 | 6 | Novartis Pharmaceuticals Corporation ($139.89) |
| 2018 | $59.58 | 4 | PFIZER INC. ($26.23) |
| 2017 | $1,057 | 69 | Genentech USA, Inc. ($222.29) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/25/2023 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 01/09/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $12.49 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/20/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/08/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/06/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $28.37 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/01/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $26.50 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/29/2019 | Novartis Pharmaceuticals Corporation | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: OPHTHALMOLOGY | ||||||
| 05/22/2018 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: ONCOLOGY | ||||||
| 04/06/2018 | PFIZER INC. | XALKORI (Drug), IBRANCE | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: ONCOLOGY | ||||||
| 03/02/2018 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONFOCUS, FOUNDATIONACT | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: ONCOLOGY | ||||||
| 01/19/2018 | Genentech USA, Inc. | VENCLEXTA (Biological) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: BioOncology | ||||||
| 12/19/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: ONCOLOGY | ||||||
| 12/18/2017 | Genentech USA, Inc. | Perjeta (Biological), Kadcyla | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: BioOncology | ||||||
| 12/14/2017 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR, VOTRIENT | Food and Beverage | In-kind items and services | $10.20 | General |
| Category: ONCOLOGY | ||||||
| 12/13/2017 | Novartis Pharmaceuticals Corporation | VOTRIENT (Drug) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2017 | Shire North American Group Inc | ELAPRASE (Biological) | Education | In-kind items and services | $99.00 | General |
| Category: GENETIC DISEASE | ||||||
| 12/06/2017 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $27.18 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 12/05/2017 | PFIZER INC. | SUTENT (Drug), INLYTA, BAVENCIO | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: ONCOLOGY;RESPIRATORY | ||||||
| 11/22/2017 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: BioOncology | ||||||
| 11/20/2017 | PFIZER INC. | CHANTIX (Drug), ELIQUIS | Food and Beverage | In-kind items and services | $11.02 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 11/16/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ONCOLOGY | ||||||
| 11/15/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $11.39 | General |
| Category: Oncology | ||||||
| 11/15/2017 | E.R. Squibb & Sons, L.L.C. | SPRYCEL (Drug) | Food and Beverage | Cash or cash equivalent | $11.00 | General |
| Category: Oncology | ||||||
| 11/15/2017 | PFIZER INC. | XTANDI (Drug) | Food and Beverage | In-kind items and services | $5.10 | General |
| Category: ONCOLOGY | ||||||
About Dr. Mohamed Kanaa, MD
Dr. Mohamed Kanaa, MD is a Hematology & Oncology healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1215932496.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Kanaa, MD has received a total of $1,282 in payments from pharmaceutical and medical device companies, with $12.80 received in 2023. These payments were reported across 81 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,170).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Oklahoma City, OK
- Active Since 06/15/2005
- Last Updated 07/08/2007
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1215932496
Products in Payments
- XIIDRA (Drug) $139.89
- ELAPRASE (Biological) $99.00
- IBRANCE (Drug) $79.84
- VENCLEXTA (Biological) $67.73
- MEKINIST (Drug) $64.71
- OPDIVO (Biological) $62.33
- Perjeta (Biological) $62.04
- TECENTRIQ (Biological) $56.36
- PROVENGE (Drug) $43.32
- SANDOSTATIN LAR (Drug) $41.08
- KEYTRUDA (Biological) $40.89
- AFINITOR (Drug) $40.73
- TASIGNA (Drug) $39.77
- BENDEKA (Drug) $38.29
- FOUNDATIONONE (Device) $31.24
- Imbruvica (Drug) $28.82
- XTANDI (Drug) $28.31
- ELIQUIS (Drug) $25.43
- SUTENT (Drug) $24.56
- CHANTIX (Drug) $23.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Oklahoma City
Robert Reynolds, Md, MD
Hematology & Oncology — Payments: $14,579
Hematology & Oncology $14,579
Philip Comp, Md, MD
Hematology & Oncology — Payments: $13,151
Hematology & Oncology $13,151
Dr. Charles Hollen, M.d, M.D
Hematology & Oncology — Payments: $12,135
Hematology & Oncology $12,135
Jennifer Holter-Chakrabarty, Md, MD
Hematology & Oncology — Payments: $11,994
Hematology & Oncology $11,994
Dr. Saadia Chohan, Md, MD
Hematology & Oncology — Payments: $11,197
Hematology & Oncology $11,197
Abby Bova, Md, MD
Hematology & Oncology — Payments: $5,791
Hematology & Oncology $5,791